A Patient-Centered Approach to Medicare Drug Reform
Dr. A. Mark Fendrick
The Trump administration has proposed sweeping changes to Medicare to curb taxpayer spending on prescription drugs. These include price setting, revamping how doctors and hospitals acquire drugs, and changing how physicians are reimbursed for medicines.
The changes apply to "Part B," the component of Medicare that covers medicines administered in a health-care facility, like gene therapies and advanced treatments for cancer. Today, physicians purchase these medications directly.